Free Trial

Cullinan Therapeutics (CGEM) Institutional Ownership

Cullinan Therapeutics logo
$16.33 +0.18 (+1.11%)
Closing price 04:00 PM Eastern
Extended Trading
$16.38 +0.05 (+0.28%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Cullinan Therapeutics (NASDAQ:CGEM)

Current
Institutional Ownership
Percentage
86.31%
Number of
Institutional Buyers
(last 12 months)
86
Total
Institutional Inflows
(last 12 months)
$86.62M
Number of
Institutional Sellers
(last 12 months)
48
Total
Institutional Outflows
(last 12 months)
$52.67M
Get CGEM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cullinan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CGEM Institutional Buying and Selling by Quarter

Cullinan Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2026 Dimensional Fund Advisors LP906,028$12.87M0.0%+6.7%1.474%
5/7/2026 AlphaCentric Advisors LLC20,135$286K0.3%+5.7%0.033%
5/5/2026 Bank of New York Mellon Corp143,708$2.04M0.0%-0.8%0.234%
4/27/2026 Y Intercept Hong Kong Ltd95,417$1.36M0.0%N/A0.158%
4/27/2026 Leonteq Securities AG10,000$142K0.0%N/A0.017%
4/22/2026 Sterling Capital Management LLC1,799$26K0.0%-41.4%0.003%
4/20/2026 Assenagon Asset Management S.A.138,705$1.97M0.0%-12.6%0.229%
3/3/2026 Caitong International Asset Management Co. Ltd4,680$48K0.0%+181.9%0.008%
2/26/2026Seven Fleet Capital Management LP3,000$31K0.0%N/A0.005%
2/19/2026 Invesco Ltd.130,323$1.35M0.0%+27.4%0.221%
2/18/2026XTX Topco Ltd121,257$1.26M0.0%-27.8%0.205%
2/18/2026Virtus Investment Advisers LLC22,318$231K0.1%+75.5%0.038%
2/18/2026Wellington Management Group LLP159,751$1.65M0.0%-5.0%0.270%
2/18/2026Susquehanna Portfolio Strategies LLC233,842$2.42M0.0%+87.8%0.396%
2/18/2026Tudor Investment Corp ET AL10,128$105K0.0%-65.1%0.017%
2/18/2026Orbimed Advisors LLC270,006$2.80M0.1%-86.0%0.457%
2/18/2026Millennium Management LLC362,495$3.75M0.0%-34.1%0.614%
2/18/2026Elmind Capital LP310,000$3.21M0.9%N/A0.525%
2/18/2026Engineers Gate Manager LP69,343$718K0.0%+37.7%0.117%
2/18/2026Boothbay Fund Management LLC1,237,043$12.80M0.2%N/A2.094%
2/17/2026ADAR1 Capital Management LLC50,000$518K0.0%N/A0.085%
2/17/2026Schonfeld Strategic Advisors LLC16,638$172K0.0%N/A0.028%
2/17/2026AQR Capital Management LLC281,483$2.91M0.0%+42.2%0.476%
2/17/2026Trexquant Investment LP381,535$3.95M0.0%+103.4%0.646%
2/17/2026Jump Financial LLC364,889$3.78M0.0%+87.6%0.618%
2/17/2026Price T Rowe Associates Inc. MD47,187$489K0.0%+9.1%0.080%
2/17/2026 Russell Investments Group Ltd.24,409$253K0.0%+471.4%0.041%
2/17/2026ExodusPoint Capital Management LP30,487$316K0.0%N/A0.052%
2/16/2026Squarepoint Ops LLC75,820$785K0.0%-16.1%0.128%
2/16/2026Mariner LLC49,131$508K0.0%+74.5%0.083%
2/16/2026Kennedy Capital Management LLC47,266$489K0.0%+2.7%0.080%
2/16/2026Barclays PLC269,655$2.79M0.0%+7.4%0.456%
2/13/2026Marshall Wace LLP414,359$4.29M0.0%+40.3%0.701%
2/13/2026The Manufacturers Life Insurance Company 16,822$174K0.0%-5.6%0.028%
2/13/2026Affinity Asset Advisors LLC1,932,106$20.00M1.1%+632.4%3.270%
2/13/2026Quarry LP9,600$99K0.0%N/A0.016%
2/13/2026Schroder Investment Management Group343,667$3.41M0.0%N/A0.582%
2/13/2026Rafferty Asset Management LLC61,671$638K0.0%+51.4%0.104%
2/13/2026Charles Schwab Investment Management Inc.436,273$4.52M0.0%+8.4%0.738%
2/13/2026State Street Corp2,197,338$22.74M0.0%+31.0%3.719%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
2/13/2026 Caitong International Asset Management Co. Ltd2,696$28K0.1%+62.4%0.005%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC48,051$497K0.0%+1.9%0.081%
2/13/2026 Wells Fargo & Company MN60,514$626K0.0%+54.7%0.102%
2/12/2026HRT Financial LP84,067$870K0.0%+99.6%0.142%
2/12/2026MetLife Investment Management LLC30,816$319K0.0%+32.6%0.052%
2/12/2026Renaissance Technologies LLC631,706$6.54M0.0%+19.3%1.069%
2/12/2026 Dimensional Fund Advisors LP848,769$8.78M0.0%-28.3%1.437%
2/12/2026EntryPoint Capital LLC23,788$246K0.1%-43.6%0.040%
2/12/2026 AlphaCentric Advisors LLC19,041$197K0.2%N/A0.032%
2/12/2026 Swiss National Bank58,300$603K0.0%+15.9%0.099%
2/12/2026 Great Lakes Advisors LLC12,403$128K0.0%N/A0.021%
2/12/2026 Nuveen LLC579,095$5.99M0.0%+168.6%0.980%
2/11/2026 Deutsche Bank AG586,636$6.07M0.0%+2.6%0.993%
2/11/2026 Fox Run Management L.L.C.21,204$219K0.0%+36.6%0.036%
2/10/2026Goldman Sachs Group Inc.721,864$7.47M0.0%-26.6%1.222%
2/9/2026Geode Capital Management LLC1,302,262$13.48M0.0%+0.5%2.204%
2/9/2026Blue Owl Capital Holdings LP2,350,972$24.33M1.8%-6.4%3.979%
2/6/2026Nano Cap New Millennium Growth Fund L P10,000$104K0.1%N/A0.017%
2/6/2026 ProShare Advisors LLC12,489$129K0.0%+15.3%0.021%
1/29/2026 UBS Group AG271,736$2.81M0.0%+44.4%0.460%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank9,909$103K0.0%+29.7%0.017%
1/26/2026CWM LLC3,876$40K0.0%+51.5%0.007%
1/20/2026 Signaturefd LLC4,130$43K0.0%+689.7%0.007%
1/16/2026 Tema Etfs LLC36,964$383K0.0%N/A0.063%
1/9/2026 SG Americas Securities LLC15,631$162K0.0%+49.4%0.026%
1/9/2026 Assenagon Asset Management S.A.158,753$1.64M0.0%-10.7%0.269%
1/1/2026JPMorgan Chase & Co.31,868$189K0.0%-67.2%0.054%
1/1/2026Tudor Investment Corp ET AL28,988$172K0.0%+30.9%0.049%
12/9/2025Tudor Investment Corp ET AL28,988$172K0.0%+30.9%0.049%
11/20/2025Voss Capital LP221,473$1.31M0.1%-12.0%0.375%
11/17/2025XTX Topco Ltd167,979$996K0.1%+289.8%0.284%
11/17/2025Wexford Capital LP5,317$32K0.0%-71.6%0.009%
11/17/2025Qube Research & Technologies Ltd152,409$904K0.0%+127.1%0.258%
11/17/2025Prelude Capital Management LLC48,652$289K0.0%+201.2%0.082%
11/17/2025Millennium Management LLC550,471$3.26M0.0%+7.8%0.932%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.25,988$154K0.0%-12.9%0.044%
11/17/2025Brevan Howard Capital Management LP45,936$272K0.0%+138.9%0.078%
11/17/2025Citadel Advisors LLC1,984,407$11.77M0.0%-19.0%3.359%
11/17/2025Bank of America Corp DE557,189$3.30M0.0%-15.7%0.943%
11/17/2025Algert Global LLC236,092$1.40M0.0%+9.5%0.400%
11/17/2025Ameriprise Financial Inc.56,777$337K0.0%+25.4%0.096%
11/14/2025 Creative Planning27,376$162K0.0%-34.4%0.046%
11/14/2025Deerfield Management Company L.P.2,927,013$17.36M0.3%-24.1%4.954%
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC47,163$280K0.0%-55.7%0.080%
11/14/2025Two Sigma Investments LP59,672$354K0.0%N/A0.101%
11/14/2025Caption Management LLC28,389$168K0.0%-107.0%0.048%
11/14/2025Squarepoint Ops LLC90,318$536K0.0%+501.8%0.153%
11/13/2025 Lynx1 Capital Management LP5,766,090$34.19M6.5%+31.0%9.760%
11/13/2025Kennedy Capital Management LLC46,011$273K0.0%+277.9%0.078%
11/13/2025 UBS Group AG188,185$1.12M0.0%-39.6%0.319%
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.tc pixel

Watch the free video to get the ticker today.
11/13/2025 BNP Paribas Financial Markets10,671$63K0.0%-91.7%0.018%
11/13/2025Franklin Resources Inc.1,416,036$8.40M0.0%-36.4%2.397%
11/13/2025Magnetar Financial LLC26,263$156K0.0%N/A0.044%
11/13/2025 Legal & General Group Plc15,295$91K0.0%-18.9%0.026%
11/13/2025 Russell Investments Group Ltd.4,272$25K0.0%-89.6%0.007%
11/13/2025Blue Owl Capital Holdings LP2,510,972$14.89M4.6%+5.2%4.250%
11/12/2025Barclays PLC251,110$1.49M0.0%-6.5%0.425%
11/12/2025 Dimensional Fund Advisors LP1,183,821$7.02M0.0%-7.3%2.004%
11/12/2025Rafferty Asset Management LLC40,729$242K0.0%+3.8%0.069%
11/12/2025 Intech Investment Management LLC27,905$165K0.0%-25.3%0.047%


CGEM Institutional Ownership - Frequently Asked Questions

During the previous two years, 153 institutional investors and hedge funds held shares of Cullinan Therapeutics. The most heavily invested institutionals were Deerfield Management Company L.P. Series C ($41.16M), Lynx1 Capital Management LP ($34.19M), RTW Investments LP ($28.56M), Holocene Advisors LP ($25.67M), Alliancebernstein L.P. ($24.50M), Blue Owl Capital Holdings LP ($24.33M), and State Street Corp ($22.74M).Learn more on Cullinan Therapeutics' institutional investors.

86.31% of Cullinan Therapeutics' stock is owned by institutional investors. Learn more on CGEM's institutional investor holdings.

Of the 136 institutional investors that purchased Cullinan Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynx1 Capital Management LP ($2.59M), Deerfield Management Company L.P. Series C ($2.24M), Affinity Asset Advisors LLC ($1.67M), Marshall Wace LLP ($1.31M), Boothbay Fund Management LLC ($1.24M), Braidwell LP ($1M), and State Street Corp ($916.06K).

Institutional investors have bought a total of 9,769,665 shares in the last 24 months. This purchase volume represents approximately $86.62M in transactions.

Of the 48 institutional investors that sold Cullinan Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($1.65M), Deerfield Management Company L.P. ($928.54K), Franklin Resources Inc. ($812.12K), Citadel Advisors LLC ($465.39K), Dimensional Fund Advisors LP ($427.77K), Goldman Sachs Group Inc. ($334.93K), and Millennium Management LLC ($238.76K).

Institutional investors have sold a total of 6,598,320 shares in the last 24 months. This volume of shares sold represents approximately $52.67M in transactions.



This page (NASDAQ:CGEM) was last updated on 5/13/2026 by MarketBeat.com Staff.
From Our Partners